SUNDAY, MAY 2, 4:00 PM - 6:00 PM
The speakers in this session will discuss the clinical and molecular aspects of various human genetic syndromes, resulting in increased susceptibility to cancer. Also, specific chromosome translocations underlying various human cancers will be considered. While these human syndromes are rare, they offer broad insights into stem cell biology and the development of cancers in the general population. 4:00 pm ---
Tyrosinemia Type I and Fanconi Anemia: Two Inherited
Cancer Susceptibility Syndromes 4:40 pm ---
Li-Fraumeni Syndrome and the p53 Gene 5:20 pm ---
Chromosome Breakage and Leukemia
This Topic Symposium will address new advances in our understanding of the pathophysiology and management of rickets. X-linked
Hypophosphatemic Rickets Molecular Regulation
and Mutations of the Vitamin D 1-Alpha Hydroxylase Gene Treatment of Rickets
MONDAY, MAY 3, 8:00 AM - 10:00 AM
Cognitive disorders affecting language, learning and behavior effect a broad range of pediatric patients. Speakers in this session will address recent advances in the development and function of the fetal cortex, especially in regard to actions of steroids, insights into cognitive disorders derived from advanced neuro-imaging techniques and new methods of neuro-rehabilitation using computer technology for specifically language impaired children. Neuroscience Based
Training Ameliorates Language Impairment Neuro-imaging in
Cognitive Disorders Neurosteroids and
Cortical Development
New discoveries in the mechanisms of programmed cell death will be reviewed. The essential nature of apoptosis in mammalian development and current and future application of these discoveries to clinical medicine will be presented. 8:00 am ---
Mitochondria: Ignition Chamber for Apoptosis 8:40 am ---
Caspases and Cell Death 9:20 am ---
Identification of Components of the Cell Death Pathway
TUESDAY, MAY 4, 8:00 AM - 10:00 AM
This topic symposium will acquaint pediatricians with this growing list of cytokine receptor defects, their clinical features, molecular bases and means of diagnosis. A portion of the session will also be devoted to an update on the status of gene therapy for one of these defects. X-linked SCID: A
Cytokine Receptor Defect as a Target for Gene Therapy
Jak3: Role in
Cytokine Signaling and the Pathogenesis of SCID
"Just Say No To
Bugs: The Interferon Gamma Pathway" * Sponsored jointly by the Pediatric Academic Societies ** Sponsored by the American Pediatric Society, Society for Pediatric Research, American Society of Pediatric Nephrology, and the Lawson Wilkins Pediatric Endocrine Society Back to
Annual Meeting Index Page Last Modified: April 06, 2000 |